Welcome Guest
Sign In
Register
Home
Bioprocessing
Chromatography
Drug Delivery
Excipients
Formulation Development
Microbiology
Spectroscopy
Articles
Issue Archives
Whitepapers / App Notes / eBooks
Infographics
Facility Tour
CGT Circuit
News
Industry News
Supplier News
All News
Products
Featured Products
New Products
Analytical Equipment
Formulation Development
Pharmaceutical Manufacturing
Excipients
All Other Products
QC Corner
Webinars
Videos
Documentaries
Company Profiles
Events
Register
Sign In
Home
Product Center
Pharmaceutical Excipients
Excipients
Excipients
Your search returned 24 Excipient Search across 1 supplier.
Showing 24 of 24 products
<<
<
>
>>
Sort By
Item Name
Company Name
Relevancy
Select All
Select up to 5 products from below to compare or request more information.
Compare
Sponsored Products
Kollisolv P 124
BASF North America
Functionality:
Solubilizer
Application:
Liquid plasticizer for tablet coatings, Solvent for APIs, dispersing agent, stabilizer and co-emulsifier in semi-solid formulations
Get quote
Compare
or
Get quote
for selected.
Kolliwax® S
BASF North America
Functionality:
Consistency factors & viscosity enhancement
Application:
Structure-building consistency factor with dry feel, forms crystalline barrier on skin
Get quote
Compare
or
Get quote
for selected.
Kollicoat MAE 30 DP
BASF North America
Functionality:
Enteric Release Coating
Application:
Enteric coating with release above pH 5.5 (30 % solids content dispersion)
Get quote
Compare
or
Get quote
for selected.
Kolliphor EL
BASF North America
Functionality:
Solubilizer
Application:
Nonionic emulsifier for O-W emulsions, Solubilizer
Get quote
Compare
or
Get quote
for selected.
Soluplus
BASF North America
Functionality:
Binder
Application:
Increase solubility and bioavailability, Ideal for hot melt extrusion (HME)
Get quote
Compare
or
Get quote
for selected.
Kolliwax® S Fine
BASF North America
Functionality:
Consistency factors & viscosity enhancement
Application:
Lipophilic lubricant, especially for sensitive acidic APIs. Matrix forming agent in sustained-release dosage forms, emulsifying and solubilizing agent in topical formulations and hardening agent in glycerin suppositories
Get quote
Compare
or
Get quote
for selected.
Kollidon® 30 LP
BASF North America
Functionality:
Binder
Application:
Binder for peroxide sensitive drugs in solid oral dosage forms. Drug solubilizer with low peroxide in transdermal patches.
Get quote
Compare
or
Get quote
for selected.
Kollisolv® GTA
BASF North America
Functionality:
Solvent, Plasticizer
Application:
Plasticizer particularly suitable for tablet coatings. Versatile water or oil miscible solvent in topical formulations
Get quote
Compare
or
Get quote
for selected.
Kollidon® 12 / 17 PF
BASF North America
Functionality:
Binder
Application:
Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products
Get quote
Compare
or
Get quote
for selected.
Kolliphor RH40
BASF North America
Functionality:
Solubilizer
Application:
Solubiliser, Plasticizer for coating & polymeric matrices, Nonionic emulsifier for O-W emulsions
Get quote
Compare
or
Get quote
for selected.
Kollidon® CL / CL-F / CL-SF
BASF North America
Functionality:
Disintegrant
Application:
Maximum disintegration
Get quote
Compare
or
Get quote
for selected.
Kollicoat MAE 100 P
BASF North America
Functionality:
Enteric Release Coating
Application:
Enteric coating with release above pH 5.5 (partially preneutralized powder)
Get quote
Compare
or
Get quote
for selected.
Kollicoat® IR
BASF North America
Functionality:
Instant Release Coating
Application:
For Instant Release Coating, Powerful and peroxide free wet binder for oxidation-sensitive drugs. Flexible and wash resistant film former in topical films.
Get quote
Compare
or
Get quote
for selected.
Kolliphor® P188 micro
BASF North America
Functionality:
Solubilizer
Application:
Dissolution enhancer, lubricant & wetting agent, Hydrophilic lubricant, effervescent tablets
Get quote
Compare
or
Get quote
for selected.
Kolliwax® HCO
BASF North America
Functionality:
Consistency factors & viscosity enhancement
Application:
Lipophilic lubricant, for sensitive acidic APIs, sustained release melt coating. Used as consistency factor to enhance the viscosity of topical formulations
Get quote
Compare
or
Get quote
for selected.
Kolliwax® SA
BASF North America
Functionality:
Consistency factors & viscosity enhancement
Application:
Lipophilic lubricant, for sensitive acidic APIs, Structure-building consistency factor for semi-solids, Viscosity regulator
Get quote
Compare
or
Get quote
for selected.
Kolliphor® P407
BASF North America
Functionality:
Solubilizer
Application:
Polymeric solubilizer, emulsifier & plasticizer, Enhances viscosity, thermoreversible gelling effect
Get quote
Compare
or
Get quote
for selected.
Kolliphor® SLS
BASF North America
Functionality:
Emulsifier
Application:
Wetting agent, reduces disintegration time, Ionic solubilizer, high HLB anionic emulsifier for semi-solids and foams
Get quote
Compare
or
Get quote
for selected.
Kolliwax® CA
BASF North America
Functionality:
Consistency factors & viscosity enhancement
Application:
Structure-building consistency factor for semi-solids. Viscosity regulator.
Get quote
Compare
or
Get quote
for selected.
Kollicream® 3C
BASF North America
Functionality:
Emollient & solvent
Application:
Medium spreadability, extremely mild, solvent for lipophilic drugs, enhances skin penetration
Get quote
Compare
or
Get quote
for selected.
Kolliwax® MA
BASF North America
Functionality:
Consistency factors & viscosity enhancement
Application:
Consistency factor with low melting point. Soft sensory effect
Get quote
Compare
or
Get quote
for selected.
Kolliwax® CSA 50
BASF North America
Functionality:
Consistency factors & viscosity enhancement
Application:
Structure-building consistency factor for semi-solids, Co-emulsifier and viscosity enhancer
Get quote
Compare
or
Get quote
for selected.
Ludiflash
BASF North America
Functionality:
Binder
Application:
Ready-to-use ODT solution with superior mouthfeel
Get quote
Compare
or
Get quote
for selected.
Kolliphor® P188
BASF North America
Functionality:
Solubilizer
Application:
Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect
Get quote
Compare
or
Get quote
for selected.
Select All
Select up to 5 products from above to compare or request more information.
Compare
Tags:
Please Login or Register to Create Tags
Feedback
Articles
Understanding and Resolving Drug Shortages in the Pharmaceutical Industry
Process Validation and Sterility Assurance: Relations and Requirements
Pharmaceutical P.I.N. Points: Patent Innovation News - March 2023
Keeping Patients in Focus: Limiting Treatment Burden for Improved Eye Care
An Update on Oral Administration of Peptides to Achieve Systemic Delivery
The Lifecycle of Drugs from Development to Approval and Market Launch
Pharmaceutical P.I.N. Points: Patent Innovation News - April 2023
Moving Towards Genome Integrity Evaluation of Gene Therapy Viral Vectors
Principles of Drug Design: How to Leverage Ligand-Receptor Molecular Interactions
Solid Lipid Nanocarrier Development Toolbox for Increasing Oral Bioavailability of API
A Discourse on Pharmaceutical cGMP FDA Form 483 Trends: Why are We Re-Living the Same Issues Over the Last 23 Years?
Modified Beta Cyclodextrin
Enhancing Formulation Development: Leveraging Specialty Chemicals for Improved Drug Delivery
Precision Medicine in Clinical Trials: A Statistical Perspective
Viatel™ Bioresorbable Polymers with High Molecular Weight Formulation
Viatel™ Ultrapure Bioresorbable Polymers
Viatel Bioresorbable Polymers
Particle Size Specifications for Solid Oral Dosage Forms: A Regulatory Perspective
Development of Freeze-dried Formulations Using Thermal Analysis and Microscopy
Quality-by-Design for Freeze-Thaw of Biologics: Concepts and Application to Bottles of Drug Substance
Application Challenges and Examples of New Excipients in Advanced Drug Delivery Systems
Amorphous Solid Dispersions as Enabling Formulations for Discovery and Early Development
Ion Chromatography in USP-NF
Parenteral Products: Pharmacopeial Control of Containers, Storage and Distribution
Evaluation of In-Situ Fiber Optics Dissolution Method for Compound A Extended Release Tablets
Compendial Standards and Excipient Performance in the QbD Era: USP Excipient Performance Chapter <1059>
Davisco Foods International, Inc. and Meggle Group announce a Joint Venture for the Production of Pharmaceutical Lactose
Hot-stage Optical Microscopy as an Analytical Tool to Understand Solid-state Changes in Pharmaceutical Materials
Advances in Lipid-based Formulations: Overcoming the Challenge of Low Bioavailability for Poorly Water Soluble Drug Compounds
Mechanism of Stabilization of Proteins by Poly-hydroxy Co-solvents: Concepts and Implications in Formulation Development
Miniaturized Equipment for Early Formulation Development
Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients (APIs)
In Vitro
High-throughput Drug Precipitation Methods for Oral Formulations
An Interview with DSM
Why is GMP Training a Necessity at Excipient Sites?
Stability Testing – Doing Everything or Doing the Right Thing?
Aptalis Pharmaceutical Technologies Sponsors 2012 Controlled Release Society’s Young Investigator Award at Annual Meeting and Exposition
Using Process Analytical Technologies for Real Time Monitoring and Quality Assurance in Chemical Development
Functionality and Performance of Excipients in a Quality-by-Design World Part X: Continuous Processing of Pharmaceutical Finished Products
Functionality and Performance of Excipients in a Quality-by-Design World, Part IX: New Excipients
New VitalDose® Blog Debuts
Functionality and Performance of Excipients in Quality-by-Design World, Part VIII: Excipient Specifications
Functionality and Performance of Excipients in Quality-by-Design World, Part VII: Quality Risk Management
Functionality and Performance of Excipients in Quality-by-Design World Part VI: Excipient Composition
Catalent Announces Commencement of Supply of Abilify® Orally Disintegrating Tablets to Otsuka Pharmaceutical Co. Ltd. and Extensive Investments to it's Zydis® to Technology Capabilities in Swindon, UK
Functionality and Performance of Excipients in Quality-by-Design World Part V: Changes in the Sourcing and Supply of Pharmaceutical Excipients
An Interview with Meggle
An Interview with DSM
Use of Enzymes in the Dissolution Testing of Gelatin Capsules
The Impact of USP’s New Elemental Impurities Standards on Manufacturers, Suppliers and Contract Laboratories
BASF Extends Offer Period for Pronova BioPharma
BASF Increases Cash Offer for Pronova BioPharma
The Innovator Pipeline: Bioavailability Challenges and Advanced Oral Drug Delivery Opportunities
BASF Starts Up tert. Butylamine plant in Nanjing, China
CPhI opens Awards to Global Pharma Industry, Celebrating Tomorrow’s Innovations Today
The Creation of an Excipient Properties Database to Support Quality by Design (QbD) Formulation Development
Controlled Release Pulmonary Therapies: Promises and Concerns
CPhI Report Indicates a Need for Greater Third Party Certification to Ensure GMP Vigilance
Aesica Appoints Ian Muir to Newly Created Commercial Managing Director Position
CPhI Announces USA Market Report at InformEx
An Interview With Jasmine Musakhanian, M.Sc. Marketing & Scientific Director of Pharmaceutical Division Gattefossé USA
CELPHERE MCC Spherical Seed Core
CEOLUS KG Grade Microcrystalline Cellulose
CEOLUS PH Grade Microcrystalline Cellulose
CEOLUS UF Grade Microcrystalline Cellulose
Soluplus
Actimask® Acetaminophen 92M
Lubrizol Invests $60 Million to Expand Particle Sciences, Vesta and Other Facilities in 2017
Gattefossé North America Announces Recipient of 2017 Award for Excellence
An Interview With Shaukat Ali, PhD
ABITEC, UNIVAR Canada Announce Specialty Lipid Distribution Agreement
Tracking Host Cell Proteins During Biopharmaceutical Manufacturing: Advanced Methodologies to Ensure High Product Quality
Facility Tour: Gattefossé - The Lipid Chemistry Experts
ABITEC Launches New Versatile Excipient for Oral Dosage Applications
FDA Finalizes Bulk Drug substances Rule
The CDMO’s Challenges for Developing Oral Suspensions for Children
An Interview With... Dr. Egmont G. Pfeifer and Dr. Albrecht Krämer of MEGGLE Group
Lipids in Transdermal and Topical Drug Delivery
World’s First Triple Compound: CombiLac® from Meggle
Taste Masking Techniques in the Pharmaceutical Industry
Trends and Innovations in Oral Drug Delivery Round Table
Roundtable: Excipient Trends/Challenges
Forensics in QbD: Addressing Foreign Particulate Matter Investigations
Hydroxypropyl Cellulose for Orally Disintegrating Film Drug Application
Micromeritics to Participate in University of Maryland Tableting Course
Natoli Debuts New Website
First GMP-Compliant Batch of a Biologic Drug Substance from a Moss Expression System Produced for Clinical Use
Catalent Announces Two Senior Executive Appointments to Support Global Development and Clinical Services Business Growth
Almac Doubles Global 2-8°C Cold Room Capacity in Response to Increasing Biologics Demand
Almac Makes Further Significant co-investment to Meet Japanese Client Demand for Humidity Controlled Blister Packaging
BASF and Colorcon Cooperate on Kollicoat
®
IR for Ready-to-Use Pharmaceutical Coating Solutions
EMD Millipore Expands its EMPROVE® Raw Materials Portfolio to 400 Products
Pharmaceutical Excipients Identification With Handheld Raman
BASF to Build New World-scale Plant for Specialty Amines in Ludwigshafen
Quotient Clinical Extends its Translational Pharmaceutics™ Platform into Cancer Drug Development
Croda Celebrates EXCiPACTTM “Double”
CPhI Pharma Awards Winners Showcase the Innovations Driving Pharma
Thermo Fisher Scientific Receives Clearance from the European Commission for its Acquisition of Life Technologies
CPhI Japan 2014: Japanese Market to Continue to Dominate Global Pharma
Catalent Pharma Solutions and Adamas Pharmaceuticals Enter Into Phase 3 Clinical Trials Manufacturing Agreement for Potential New Treatment for Levodopa Induced Dyskinesia
BASF Received EXCiPACTTM Certification as Pharmaceutical Excipient Supplier
Chris Kilbee Appointed Group Director of UBM Pharma Portfolio
The Future of Pharmaceutical Excipients: A $14 Billion Market Driven by Global Demand
Microbiologics Announces New CEO
Particle Engineering For Improved Bioavailability In Oral Solid Dose Medications
Noramco, SPI Pharma Announce Availability of Excipient Compatibility Study for Cannabidiol Solid Oral Dosage Forms
MEGGLE Appoints Barentz as its Exclusive Distributor of Pharmaceutical-Grade Lactose for United States
Ginkgo Bioworks Announces Collaboration with Merck to Improve API Manufacturing
Ashland Injectable Excipient Accepted Into FDA Novel Excipient Review Program
Key Considerations for Stabilizing Oxidation-Prone Lipid-Based Drug Delivery Systems
DFE Pharma Expands Co-Processed Portfolio
Merck KGaA: Allergopharma Plans to Invest € 40 Million in Production Facility
Expert Presentations at Australia Workshop on Powder Characterisation and Inhaler Testing
CPhI Worldwide 2013 Hosted More Than 34,000 Global Pharma Professionals with Expanded Content and First Annual Report
Vetter Launches New Clinical Syringe Packages
The New Dawn of Pharmaceutical Manufacturing: Innovative Solutions for Unprecedented Challenges
Colorcon, Inc. Launches First Certified Organic Coating System for Dietary Supplement Tablets
Tergus Grows Manufacturing Capabilities Tergus Grows Manufacturing Capabilities
Investigation of Excipient Compatibility and Associated Degradations for the Formulation Development of a Small Molecule Pharmaceutical Compound
Rapid Detection of Counterfeit Drugs of Ethambutol Hydrochloride and Cefuroxime Axetil using Handheld Raman, Near Infrared and Portable FTIR Technologies
Future of Transdermal Drug Delivery Systems (TDDS)
Are HPLC-UV Methods Fit for Purpose as True Arbiters of Quality for APIs?
A Recent Advancement in Orally Disintegrating Formulations
BASF pharmaceutical solutions presented at CPhI Worldwide in Frankfurt, Germany
API, Excipient, and Dosage Form Characterization Solutions for the Identity and Control of Critical Quality Attributes (CQA)
Utilizing a Novel Disperser Technology to Accelerate Sample Extraction of Pharmaceutical Solid Dosage Forms
Solid State Considerations for Early Development
Crodasol HS HP
“Joshi Capsules” US patent numbers – 8728521 and 9884024
The KEY TO Pharma’s Next Generation Success
The Evaluation of Dual Laser Handheld Raman Spectroscopy for Identifying Novel Psychoactive Substances
Automated and Rapid Methods to Assess Quality & Stability of Biologics: Recent Developments and Practical Ways to Implement Them in Formulation Development
Drug Delivery Roundtable
Elemental Impurities: Implications for Manufacturers of Drug Products, APIs, and Excipients
Theory of Sampling (TOS) for Development of Spectroscopic Calibration Models
An Interview With Andreas Gryczke, Global Technical Marketing Solubilization BASF Pharma Solutions
Raw Materials and Functional Excipients Roundtable
Benefits of Using High-Functionality Excipients in a Continuous Manufacturing Process
ABITEC Improves Solubility of Topical, Transdermal Applications with Functional Lipid Excipients
Recent Innovations in Pharmaceutical Hot Melt Extrusion
Johnson & Johnson Appoints Senior Leaders to Executive Committee
CURE Pharmaceutical Debuts CUREform Drug Delivery Line
ReForm Biologics, MilliporeSigma Announce Licensing Agreement
Valneva and IDT Biologika Terminate their COVID-19 Collaboration
New Pancreatic Cancer Drug Receives Orphan Drug Designation by FDA
Roquette Acquires Qualicaps
Antibody-Drug Conjugates (ADCs): Potent Cancer Killers with PK Challenges
Pharmaceutical P.I.N. Points: Patent Innovation News
Lubrizol Licenses Apisolex Excipient to Welton Pharmaceuticals to Develop Novel Cancer Therapeutic
Reader Quiz: Drug Development Challenges
Vibrational Spectroscopy for the Analysis of Dissolved Active Pharmaceutical Ingredients
VITAMIN C – Tableting with LUBRITAB® RBW Lubricant
Nanoparticle Technologies: Enablers for Ocular Drug Delivery
Pharmaceutical PIN Points
CPhI Japan Postponed
Subscriptions
Get started here for your complimentary
print or digital subscription
Sign up Now »
Excipients
Clear
Search By
Keywords
Dosage Form
Process
Apply Changes
Blending
Capsule Filling
Cell Culture
Chelation
Compaction
Direct Compression
Dry Blending
Dry Compression
Dry Granulation
Extrusion
Extrusion spheronisation
Film Coating
Film Formation
Freeze Drying
Hot Melt Extrusion
Injectable Formulation
Melt Coating
Melt Congealing
Melt Spraying
Molecular Encapsulation
Protein Stabilization
Roller Compaction
Sachet Filling
SMEDDS
Solid Lipid Nanoparticles
Solubilization
Spheronization
Spray Congealing
Spray Drying
Supercritical Fluid Extraction
Viscosity Modification
Wet Granulation
Functionality
Apply Changes
Acidifier
Active Pharmaceutical Ingredient
Adhesive
Anti-adherant
Binder
Blending
Capsule Filling
Capsule Shell
Carrier
Cell Culture Ingredient
Co-processed
Coating Systems
Compaction
Controlled Release
Crystallization Inhibitor
Diluent
Direct Compression
Disintegrant
Dispersion
Dry Granulation
Dry Powder Inhalation
Effervescent System
Emulsifier
Extended Drug Release
Filler
Film Formation
Film Former
Flavor
Flow Aid
Freeze Drying
Gastrointestinal Dispersion
Granulation
High-Functionality
Hot Melt Extrusion
Increased Bioavailability
Isotonic Agent
Lipid
Lubricant
Mechanical strength
Modified Release
Multifunctional
Natural Origin
Nutritional Agent
Penetration Enhancer
Permeation Enhancer
pH Modifier
pH regulation
Pigment
Plasticizer
Powder Blends
Preservative
Rapid Release Agent
Sachet Filling
Solubility Enhancement
Solubilizer
Solvent
Spray Drying
Stabilizer
Surfactant
Sustained Release
Sweetener
Tablet Compressibility
Tablet Ejection
Targeted Delivery
Taste Masking
Therapeutic Agent
Thickener
Viscosity Modifier
Wet Binder
Wet Granulation
Dosage Form
Apply Changes
Film
Implant
Liquid
Multiple Dosage Forms
Parenteral
Pulmonary
Semi-solid
Suppository
Tablet
Transdermal
Companies
Apply Changes
BASF North America
Featured Products
Viatel™ Bioresorbable Polymers with High Molecular Weight Formulation
Viatel™ Ultrapure Bioresorbable Polymers
Modified Beta Cyclodextrin
Connect with Us